cbdMD Inc. (YCBD)
NYSE: YCBDConsumer DiscretionaryPackage Goods/CosmeticsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
YCBD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.84M
- P/E (TTM)
- 1.57
- EPS (TTM)
- $0.23
- Dividend yield
- None
- 52-week range
- 0.33 – 2.56
- Day range
- 0.3425 – 0.3688
- Volume / Avg
- 121.30K / 398.45K
- Beta
- —
- Shares outstanding
- 13.43M
- Next earnings
- Dec 18, 2026
52-week range
YCBD stock today
Shares of cbdMD (YCBD) finished lower on Nov 20 at $0.36, a drop of 5.11% or $0.0194 per share, versus the S&P 500's 3.70% decline. Trading was light, with 121.30K shares changing hands, about 30% of the average daily volume. At this level, YCBD sits near the bottom of its 52-week range of $0.33 to $2.56: 85.9% below the high and 9.1% above the low.
At 1.6x trailing earnings, cbdMD trades below the peer-group median of 12.6x. cbdMD's next earnings report is expected on Dec 18, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About cbdMD
Company profilecbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands.
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- CEO
- Mr. T. Ronan Kennedy
- Headquarters
- Charlotte, NC
- Employees
- 42
- IPO year
- 2017
- Website
- cbdmd.com
Financial highlights
Full financialsIn fiscal 2025, cbdMD generated $19.2 million in revenue, down 1.5% from fiscal 2024, its first annual decline since 2024. cbdMD reported a net loss of $2.0 million, compared with a loss of $3.7 million a year earlier. Gross margin was 62.4% (up from 61.6%) and operating margin -11.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $19.19M | $19.48M | $24.16M | $35.40M | $44.48M |
| Growth | -1.50% | -19.35% | -31.77% | -20.41% | +6.20% |
| Net income | $-2.04M | $-3.70M | $-22.94M | $-70.08M | $-23.39M |
| EPS (diluted) | $-1.09 | $-14.29 | $-13.32 | $-55.80 | $-0.47 |
Analyst forecast
ForecastConsensus (1 analysts)
none
- Strong buy 0
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Dec 18, 2026
- Last reported (Q3 2026)
- Aug 13, 2026
- EPS actual vs est.
- $-0.11 vs —
cbdMD peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BIOTInstinct Bio Technical Company Holdings Inc. | 0.1432 | -12.15% | $4.12M | vs YCBD |
| BNKKBonk Inc. | 0.4558 | -3.41% | $3.91M | vs YCBD |
| CABRCaring Brands Inc. | 0.66 | 0.00% | $7.59M | vs YCBD |
| BYAHPark Ha Biological Technology Co. Ltd. Class A | 0.8501 | -18.26% | $16.59M | vs YCBD |
| AXILAXIL Brands Inc. | 4.27 | -5.22% | $29.13M | vs YCBD |
| UGUnited-Guardian Inc. | 7.35 | +4.11% | $33.77M | vs YCBD |
| WNWMeiwu Technology Company Limited | 1.65 | -13.42% | $43.31M | vs YCBD |
| SLSNSolesence Inc. | 1.41 | -4.73% | $99.61M | vs YCBD |
Indexes, lists and sector
Largest Consumer Discretionary stocks
cbdMD stock FAQ
What is cbdMD's stock price today?
YCBD last traded at $0.36 as of Nov 20, 4:00 PM EST, down 5.11% on the day. Prices are delayed at least 15 minutes.
When is cbdMD's next earnings date?
cbdMD is expected to report earnings on Friday, December 18, 2026.
What is YCBD's P/E ratio?
YCBD trades at a trailing P/E ratio of 1.57, compared with a median of 12.6 for its closest peers.
Who is cbdMD's CEO?
Mr. T. Ronan Kennedy is the chief executive officer of cbdMD Inc., which has about 42 employees.
What is the YCBD 52-week high?
The 52-week high for YCBD is $2.56 and the 52-week low is $0.33. The stock is currently 85.9% below its high.